CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. TOP PLAYER POSITIONING
3.4. PATENTS ANALYSIS

3.4.1. Patent analysis by year
3.4.2. Patent analysis by region

3.5. PORTERS FIVE FORCES ANALYSIS
3.6. MARKET DYNAMICS

3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

CHAPTER 4 GLOBAL PRECISION MEDICINE MARKET, BY TECHNOLOGY

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. GENOMICS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast

4.3. TRANSCRIPTOMICS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast

4.4. EPIGENOMICS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast

CHAPTER 5 GLOBAL PRECISION MEDICINE MARKET, BY SEQUENICNG TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. SEQEUNCING BY SYNTHESIS (SBS)

5.2.1. Market size & forecast

5.3. ION SEMICONDUCTOR SEQUENCING (ISS)

5.3.1. Market size & forecast

5.4. SEQEUNCING BY LIGATION (SBL)

5.4.1. Market size & forecast

5.5. PYROSEQUENCING

5.5.1. Market size & forecast

5.6. SINGLE MOLECULE REAL TIME SEQUENCING (SMRT)

5.6.1. Market size & forecast

5.7. NANOPORE SEQUENCING

5.7.1. Market size & forecast

CHAPTER 6 GLOBAL PRECISION MEDICINE MARKET, BY PRODUCT

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. CONSUMABLES

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size & forecast

6.3. INSTRUMENTS

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size & forecast

6.4. SERVICES

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size & forecast

CHAPTER 7 GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION

7.1. OVERVIEW

7.1.1. Market size & forecast

7.2. ONCOLOGY

7.2.1. Market size & forecast

7.3. CENTRAL NERVOUS SYSTEM (CNS)

7.3.1. Market size & forecast

7.4. IMMUNOLOGY

7.4.1. Market size & forecast

7.5. RESPIRATORY MEDICINE

7.5.1. Market size & forecast

7.6. INFECTION

7.6.1. Market size & forecast

7.7. OTHER APPLICATION

7.7.1. Market size & forecast

CHAPTER 8 GLOBAL PRECISION MEDICINE MARKET, BY END USERS

8.1. OVERVIEW

8.1.1. Market size & forecast

8.2. PHARMA & BIOTECH COMPANIES

8.2.1. Market size & forecast

8.3. DIAGNOSTIC TOOL COMPANIES

8.3.1. Market size & forecast

8.4. HEALTHCARE IT/ BIG DATA COMPANIES

8.4.1. Market size & forecast

8.5. CLINICAL LABORATORIES

8.5.1. Market size & forecast

CHAPTER 9 GLOBAL PRECISION MEDICINE MARKET, BY GEOGRAPHY

9.1. OVERVIEW
9.2. NORTH AMERICA

9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size & forecast

9.2.3.1. U.S. market size and forecast
9.2.3.2. Canada market size and forecast
9.2.3.3. Mexico market size and forecast

9.3. EUROPE

9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size & forecast

9.3.3.1. Germany market size and forecast
9.3.3.2. France market size and forecast
9.3.3.3. UK market size and forecast
9.3.3.4. Italy market size and forecast
9.3.3.5. Spain market size and forecast
9.3.3.6. Rest of Europe market size and forecast

9.4. ASIA-PACIFIC

9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size & forecast

9.4.3.1. Japan market size and forecast
9.4.3.2. China market size and forecast
9.4.3.3. Australia market size and forecast
9.4.3.4. India market size and forecast
9.4.3.5. South Korea market size and forecast
9.4.3.6. Taiwan market size and forecast
9.4.3.7. Rest of Asia-Pacific market size and forecast

9.5. LAMEA

9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size & forecast

9.5.3.1. Brazil market size and forecast
9.5.3.2. Turkey market size and forecast
9.5.3.3. Saudi Arabia market size and forecast
9.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 10 COMPANY PROFILES

10.1. ILLUMINA, INC

10.1.1. Operating business segments
10.1.2. Business performance
10.1.3. Key strategic moves and developments

10.2. THERMO FISHER SCIENTIFIC, INC

10.2.1. Operating business segments
10.2.2. Business performance
10.2.3. Key strategic moves and developments

10.3. ROCHE HOLDING AG (ROCHE)

10.3.1. Operating business segments
10.3.2. Business performance
10.3.3. Key strategic moves and developments

10.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LCAH)

10.4.1. Operating business segments
10.4.2. Business performance
10.4.3. Key strategic moves and developments

10.5. QUEST DIAGNOSTICS (QD)

10.5.1. Operating business segments
10.5.2. Business performance
10.5.3. Key strategic moves and developments

10.6. QIAGEN N.V.,

10.6.1. Operating business segments
10.6.2. Business performance
10.6.3. Key strategic moves and developments

10.7. ASTRAZENECA

10.7.1. Operating business segments
10.7.2. Business performance
10.7.3. Key strategic moves and developments

10.8. NOVARTIS AG (NAG)

10.8.1. Operating business segments
10.8.2. Business performance
10.8.3. Key strategic moves and developments

10.9. BRISTOL-MYERS SQUIBB (BMS)

10.9.1. Operating business segments
10.9.2. Business performance
10.9.3. Key strategic moves and developments

10.10. ELI LILLY & COMPANY (ELC)

10.10.1. Operating business segments
10.10.2. Business performance
10.10.3. Key strategic moves and developments